These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors that influence the volatile organic compound content in human breath. Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379 [TBL] [Abstract][Full Text] [Related]
3. On the importance of accurate quantification of individual volatile metabolites in exhaled breath. Smith D; Španěl P J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619 [TBL] [Abstract][Full Text] [Related]
4. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study. Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569 [TBL] [Abstract][Full Text] [Related]
5. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018 [TBL] [Abstract][Full Text] [Related]
7. Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders. Pleil JD; Stiegel MA; Risby TH J Breath Res; 2013 Mar; 7(1):017107. PubMed ID: 23445880 [TBL] [Abstract][Full Text] [Related]
8. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
9. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Sun X; Shao K; Wang T Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028 [TBL] [Abstract][Full Text] [Related]
10. Volatile disease biomarkers in breath: a critique. Kwak J; Preti G Curr Pharm Biotechnol; 2011 Jul; 12(7):1067-74. PubMed ID: 21466456 [TBL] [Abstract][Full Text] [Related]
11. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers. Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420 [TBL] [Abstract][Full Text] [Related]
12. Real time analysis of volatile organic compounds (VOCs) in centenarians. Mazzatenta A; Pokorski M; Di Giulio C Respir Physiol Neurobiol; 2015 Apr; 209():47-51. PubMed ID: 25542135 [TBL] [Abstract][Full Text] [Related]
13. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966 [TBL] [Abstract][Full Text] [Related]
14. Sniffing Out Paediatric Gastrointestinal Diseases: The Potential of Volatile Organic Compounds as Biomarkers for Disease. Buijck M; Berkhout DJ; de Groot EF; Benninga MA; van der Schee MP; Kneepkens CM; de Boer NK; de Meij TG J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):585-591. PubMed ID: 27875502 [TBL] [Abstract][Full Text] [Related]
15. Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction. Küppers L; Holz O; Schuchardt S; Gottlieb J; Fuge J; Greer M; Hohlfeld JM J Breath Res; 2018 Jun; 12(3):036023. PubMed ID: 29771243 [TBL] [Abstract][Full Text] [Related]
16. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis. Dallinga JW; Smolinska A; van Schooten FJ Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934 [TBL] [Abstract][Full Text] [Related]
17. Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT-MS quantification of single metabolites. Smith D; Spanel P J Breath Res; 2015 Apr; 9(2):022001. PubMed ID: 25830501 [TBL] [Abstract][Full Text] [Related]
18. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437 [TBL] [Abstract][Full Text] [Related]
19. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711 [TBL] [Abstract][Full Text] [Related]
20. Detection of trace volatile organic compounds in spiked breath samples: a leap towards breathomics. Ray B; Parmar S; Vijayan V; Vishwakarma S; Datar S Nanotechnology; 2022 Feb; 33(20):. PubMed ID: 35042201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]